Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 
This study aimed to examine the views of people who use drugs and who are deeply impacted by drug policies to understand the perceived impacts and role of government under a legalized-regulated market
Original research | 2020
Policy/Regulatory, Decriminalization/legalization, Equity, About PWUD, Peer/PWLLE program involvement
To determine treatment seeking behaviour in those with opioid use disorder (OUD) in the high-income countries.
Lit review | 2021
About PWUD, Barriers and enablers
We reconsider the arguments made about the potential consequences of legalization for youth, centered on three key concerns: that prevalence would significantly increase, that there would be greater i
Original research | 2021
Evidence base, Policy/Regulatory, Decriminalization/legalization, Equity, Youth
Extended-release naltrexone (XR-NTX), an opioid antagonist, has demonstrated equal treatment outcomes, in terms of safety, opioid use, and retention, to the recommended OMT medication buprenorphine.
Original research | 2021
About PWUD, Substitution/OAT
We examine the qualitative accounts of people who use drugs engaged in ‘peer’ work in harm reduction settings across British Columbia.
Original research | 2020
Equity, About PWUD, Workplace, Peer/PWLLE program involvement, Social benefits
Commentary | 2020
Policy/Regulatory, About prescribers, About PWUD, Barriers and enablers, Substitution/OAT, Stigma
Three models to support jurisdiction specific discussions around the world.
Commentary | 2021
Policy/Regulatory
Guide or handbook | 2020
Clinical guidance, Harm reduction, Illegal drugs, Injecting tablets
Examine key characteristics and outcomes of men in Canadian federal correctional institutions across treatment modalities.
Original research | 2022
Outcomes, Justice system/law enforcement
This qualitative study was conducted to better understand how people who inject drugs (PWID) came to recognize fentanyl as a growing adulterant of heroin and the subsequent sensory discernment strateg
Original research | 2022
Harm reduction, About PWUD, Illegal drugs, Stimulants
Because those who misuse fentanyl are often a hidden and high risk group, innovative methods for identifying individuals at risk for fentanyl misuse are needed.
Original research | 2021
Harm reduction, Illegal drugs, Digital health
To test the efficacy of 3 interventions for opioid dependence: (1) screening and referral to treatment (referral); (2) screening, brief intervention, and facilitated referral to community-based treatm
Original research | 2015
About prescribers, Outcomes, Illegal drugs, Substitution/OAT, Transitions in care/treatment, Hospitals
The declaration of an overdose public health emergency in Vancouver has generated an “affective churn” of intervention across youth‐focused drug treatment settings, including the expanded provision of
Original research | 2021
Wrap-around services, About PWUD, Social services, Housing, Illegal drugs, Youth, Indigenous, Substitution/OAT
To explore OST patients’ past and present experiences of substance use stigma in healthcare settings
Original research | 2021
Barriers and enablers, Stigma
While opioid agonist therapy (OAT) reduces the risk of hepatitis C virus (HCV) acquisition among people who inject drugs (PWID), protective effects may be attenuated in females.
Original research | 2020
Harm reduction, Advocacy, Outcomes, Sex/Gender
Commentary | 2020
Safer supply, Equity, Barriers and enablers, Poverty, Stimulants, Peer/PWLLE program involvement
Commentary | 2020
Harm reduction, Policy/Regulatory, About prescribers, Illegal drugs, Stigma, SCS/OPS, Hospitals
Archived webinar | 2021
Harm reduction, Policy/Regulatory, Safer supply, Decriminalization/legalization, Advocacy, About PWUD, Illegal drugs

Support pharmacists in naloxone provision, overdose prevention, etc.

Commentary | 2017
Overdose, Hesitancy of prescribers , About pharmacists
Aimed to model the effect of Australia's first Medically Supervised Injecting Centre (MSIC) on acquisitive crime and loitering by drug users and dealers
Original research | 2009
Crime, Illegal drugs, SCS/OPS

Affiner votre recherche

Mots clés
Format
Région